DOI QR코드

DOI QR Code

Transarterial Embolization for Sporadic Renal Angiomyolipoma: Patient Selection and Technical Considerations for Optimal Therapeutic Outcomes

산발성 신장 혈관근지방종에 대한 경동맥 색전술: 최적의 치료 결과를 위한 환자 선택 및 기술적 고려 사항

  • Yena Jung (Department of Radiology Dankook University Hospital, Dankook University College of Medicine) ;
  • Min Jeong Choi (Department of Radiology Dankook University Hospital, Dankook University College of Medicine) ;
  • Bong Man Kim (Department of Radiology Dankook University Hospital, Dankook University College of Medicine) ;
  • You Me Kim (Department of Radiology Dankook University Hospital, Dankook University College of Medicine) ;
  • Yumi Seo (Department of Urology Dankook University Hospital, Dankook University College of Medicine)
  • 정예나 (단국대학교 의과대학 단국대학교병원 영상의학과) ;
  • 최민정 (단국대학교 의과대학 단국대학교병원 영상의학과) ;
  • 김봉만 (단국대학교 의과대학 단국대학교병원 영상의학과) ;
  • 김유미 (단국대학교 의과대학 단국대학교병원 영상의학과) ;
  • 서유미 (단국대학교 의과대학 단국대학교병원 비뇨의학과)
  • Received : 2021.06.28
  • Accepted : 2021.09.04
  • Published : 2022.05.01

Abstract

Although renal angiomyolipoma (AML) is a benign tumor, treatment may be necessary occasionally because it can cause potentially life-threatening retroperitoneal hemorrhage. Transarterial embolization (TAE) is a safe and effective treatment option to prevent the hemorrhagic rupture of AMLs and relieve the symptoms caused by enlarged lesions or active bleeding. However, there is no clear consensus regarding the indications for prophylactic TAE in patients with sporadic renal AMLs. In urgent TAE for bleeding AMLs, there is a likelihood of incomplete embolization when the focus is on stabilizing the clinical symptoms. This pictorial essay discusses the patient selection and technical considerations to achieve optimal therapeutic effects as well as the follow-up findings after TAE.

신장 혈관근지방종은 양성이지만 잠재적으로 생명을 위협할 정도의 후복막강 출혈을 일으킬 수 있으므로 때때로 치료가 필요하다. 경동맥색전술은 혈관근지방종의 출혈성 파열을 예방하고 병변의 비대 또는 출혈로 인한 증상을 완화시킬 수 있는 안전하고 효과적인 치료 방법 중 하나이다. 그러나 산발성 신장 혈관근지방종 환자의 예방적 색전술 시술에 대한 치료기준에 대해서는 명확한 합의가 없다. 게다가 종양 파열에서 시행하는 응급 시술에서는 임상증상의 안정화에 초점을 맞춘 불완전한 색전술의 가능성이 있다. 본 임상화보에서는 사례들을 통해 최적의 치료 효과를 위한 환자 선택 및 색전술의 기술적 및 시술 후 고려 사항을 제시하고자 한다.

Keywords

References

  1. Fernandez-Pello S, Hora M, Kuusk T, Tahbaz R, Dabestani S, Abu-Ghanem Y, et al. Management of sporadic renal angiomyolipomas: a systematic review of available evidence to guide recommendations from the European Association of Urology Renal Cell Carcinoma Guidelines Panel. Eur Urol Oncol 2020;3:57-72
  2. Planche O, Correas JM, Mader B, Joly D, Mejean A, Helenon O. Prophylactic embolization of renal angiomyolipomas: evaluation of therapeutic response using CT 3D volume calculation and density histograms. J Vasc Interv Radiol 2011;22:1388-1395
  3. Jinzaki M, Silverman SG, Akita H, Nagashima Y, Mikami S, Oya M. Renal angiomyolipoma: a radiological classification and update on recent developments in diagnosis and management. Abdom Imaging 2014;39:588-604
  4. Flum AS, Hamoui N, Said MA, Yang XJ, Casalino DD, McGuire BB, et al. Update on the diagnosis and management of renal angiomyolipoma. J Urol 2016;195:834-846
  5. Murray TE, Lee MJ. Are we overtreating renal angiomyolipoma: a review of the literature and assessment of contemporary management and follow-up strategies. Cardiovasc Intervent Radiol 2018;41:525-536
  6. Seyam RM, Alkhudair WK, Kattan SA, Alotaibi MF, Alzahrani HM, Altaweel WM. The risks of renal angiomyolipoma: reviewing the evidence. J Kidney Cancer VHL 2017;4:13-25
  7. Chan CK, Yu S, Yip S, Lee P. The efficacy, safety and durability of selective renal arterial embolization in treating symptomatic and asymptomatic renal angiomyolipoma. Urology 2011;77:642-648
  8. Bhatt JR, Richard PO, Kim NS, Finelli A, Manickavachagam K, Legere L, et al. Natural history of renal angiomyolipoma (AML): most patients with large AMLs >4 cm can be offered active surveillance as an initial management strategy. Eur Urol 2016;70:85-90
  9. Lee KH, Tsai HY, Kao YT, Lin HC, Chou YC, Su SH, et al. Clinical behavior and management of three types of renal angiomyolipomas. J Formos Med Assoc 2019;118:162-169
  10. Oesterling JE, Fishman EK, Goldman SM, Marshall FF. The management of renal angiomyolipoma. J Urol 1986;135:1121-1124
  11. Anis O, Rimon U, Ramon J, Khaitovich B, Zilberman DE, Portnoy O, et al. Selective Selective arterial embolization for large or symptomatic renal angiomyolipoma: 10 years of follow-up. Urology 2020;135:82-87
  12. Ouzaid I, Autorino R, Fatica R, Herts BR, McLennan G, Remer EM, et al. Active surveillance for renal angiomyolipoma: outcomes and factors predictive of delayed intervention. BJU Int 2014;114:412-417
  13. Hocquelet A, Cornelis F, Le Bras Y, Meyer M, Tricaud E, Lasserre AS, et al. Long-term results of preventive embolization of renal angiomyolipomas: evaluation of predictive factors of volume decrease. Eur Radiol 2014;24:1785-1793
  14. Yamakado K, Tanaka N, Nakagawa T, Kobayashi S, Yanagawa M, Takeda K. Renal angiomyolipoma: relationships between tumor size, aneurysm formation, and rupture. Radiology 2002;225:78-82
  15. Rimon U, Duvdevani M, Garniek A, Golan G, Bensaid P, Ramon J, et al. Large renal angiomyolipomas: digital subtraction angiographic grading and presentation with bleeding. Clin Radiol 2006;61:520-526
  16. Lee W, Kim TS, Chung JW, Han JK, Kim SH, Park JH. Renal angiomyolipoma: embolotherapy with a mixture of alcohol and iodized oil. J Vasc Interv Radiol 1998;9:255-261
  17. Zapardiel I, Delafuente-Valero J, Bajo-Arenas JM. Renal angiomyolipoma during pregnancy: review of the literature. Gynecol Obstet Invest 2011;72:217-219
  18. Urbano J, Paul L, Cabrera M, Alonso-Burgos A, Gomez D. Elective and emergency renal angiomyolipoma embolization with ethylene vinyl alcohol copolymer: feasibility and initial experience. J Vasc Interv Radiol 2017;28:832-839
  19. Lin L, Li X, Guan H, Wang J, Tong X, Yang M, et al. Renal function, complications, and outcomes of a reduction in tumor size after transarterial embolization for renal angiomyolipomas: a meta-analysis. J Int Med Res 2019;47:1417-1428
  20. Hongyo H, Higashihara H, Osuga K, Kashiwagi E, Kosai S, Nagai K, et al. Efficacy of prophylactic selective arterial embolization for renal angiomyolipomas: identifying predictors of 50% volume reduction. CVIR Endovasc 2020;3:84
  21. Zhang X, Kuwatsuru R, Toei H, Yashiro D, Okada S, Kato H. Can we predict the existence of extrarenal feeders to renal angiomyolipomas? Eur Radiol 2019;29:2499-2506
  22. Rimon U, Duvdevani M, Garniek A, Golan G, Bensaid P, Ramon J, et al. Ethanol and polyvinyl alcohol mixture for transcatheter embolization of renal angiomyolipoma. AJR Am J Roentgenol 2006;187:762-768
  23. Wong KM, Tan BS, Taneja M, Wong SY, Loke JS, Lin SE, et al. Cone beam computed tomography for vascular interventional radiology procedures: early experience. Ann Acad Med Singap 2011;40:308-314
  24. Bishay VL, Crino PB, Wein AJ, Malkowicz SB, Trerotola SO, Soulen MC, et al. Embolization of giant renal angiomyolipomas: technique and results. J Vasc Interv Radiol 2010;21:67-72
  25. Razik A, Das CJ, Sharma S. Angiomyolipoma of the kidneys: current perspectives and challenges in diagnostic imaging and image-guided therapy. Curr Probl Diagn Radiol 2019;48:251-261
  26. Lenton J, Kessel D, Watkinson AF. Embolization of renal angiomyolipoma: immediate complications and long-term outcomes. Clin Radiol 2008;63:864-870
  27. Sawada Y, Shimohira M, Hashizume T, Sobue R, Mori S, Nakagawa M, et al. Transcatheter arterial embolization for renal angiomyolipoma using a micro-balloon catheter and a mixture of ethanol and lipiodol. Cardiovasc Intervent Radiol 2017;40:1933-1939
  28. Murray TE, Doyle F, Lee M. Transarterial embolization of angiomyolipoma: a systematic review. J Urol 2015;194:635-639
  29. Villalta JD, Sorensen MD, Durack JC, Kerlan RK, Stoller ML. Selective arterial embolization of angiomyolipomas: a comparison of smaller and larger embolic agents. J Urol 2011;186:921-927
  30. Lee SY, Hsu HH, Chen YC, Huang CC, Wong YC, Wang LJ, et al. Embolization of renal angiomyolipomas: short-term and long-term outcomes, complications, and tumor shrinkage. Cardiovasc Intervent Radiol 2009;32:1171-1178
  31. Thulasidasan N, Sriskandakumar S, Ilyas S, Sabharwal T. Renal angiomyolipoma: mid-to long-term results following embolization with onyx. Cardiovasc Intervent Radiol 2016;39:1759-1764
  32. Patatas K, Robinson GJ, Ettles DF, Lakshminarayan R. Patterns of renal angiomyolipoma regression post embolisation on medium- to long-term follow-up. Br J Radiol 2013;86:20120633
  33. El Rafei M, Renard B, Puech P, Devos P, Gaillard V, Lemaitre L. Tumor necrosis after preventive embolization of large renal angiomyolipomas. Diagn Interv Imaging 2015;96:579-587
  34. Kuusk T, Biancari F, Lane B, Tobert C, Campbell S, Rimon U, et al. Treatment of renal angiomyolipoma: pooled analysis of individual patient data. BMC Urol 2015;15:123
  35. Boorjian SA, Frank I, Inman B, Lohse CM, Cheville JC, Leibovich BC, et al. The role of partial nephrectomy for the management of sporadic renal angiomyolipoma. Urology 2007;70:1064-1068